Pål Ryfors

PÅL RYFORS – CEO

@palryfors

Born: 1983

Pål has a Bachelor in Financial Economics from Gothenburg School of Economics. He has vast experience from leading positions within the finance and banking sector both in the Nordics and internationally.

Pål has been CFO of Marginalen Bank, a Swedish bank employing some 350 people. Prior to that, he was Head of Group Controlling at Hoist Finance. Before joining Hoist Finance, he was an investment banker at Societe Generale in London, a position he assumed after holding several leading positions in the restructuring of the Swedish operations of Kaupthing Bank.

Other appointments: Chairman Aros Kapital, Board member Vivesto AB (publ) and Stora Rosenvik Bostadsrättsförening

No of B shares: 3,000,000

No of employee stock options: 732,734

No of performance options: 1,870,489

No of warrants: 1,651,427

 

 

 

Veronica Wallin

VERONICA WALLIN – CFO

Born: 1986

Veronica has a Degree of Master of Science in Business and Economics from Stockholms University and was employed by Episurf Medical in August 2016 as Head of Finance. In June 2017 Veronica became CFO after Pål Ryfors, who then resigned as CFO.

Prior to joining Episurf Medical Veronica worked as Head of Finance at ApoEx during 2013-2016. Veronica was a Board Member of Alligator Bioscience AB (publ) 2021-2024.

Other appointments: Board member IRLAB Therapeutics AB (publ) and Integrative Research Laboratories Sweden AB.

No of B shares: 112,148

No of employee stock options: –

No of performance options: 576 517

No of warrants: –

 

 

 

 

 

KATARINA FLODSTRÖM – COO

Born: 1975

Katarina has a PhD in Physical Chemistry from Lund University and a MSc in Chemical Engineering from the Royal Institute of Technology in Stockholm. She was employed by Episurf Medical in 2014. Katarina has more than 15 years’ experience from RnD in start-up companies. She was the RnD Manager and Quality Manager of Diamorph AB from which Episurf is a spin-off.

Other appointments:-

No of B shares: 103,125 (of which 28,875 is family members)

No of employee stock options: –

No of performance options: 558,700

No of warrants: –

 

 

 

 

Fredrik Zetterberg

FREDRIK ZETTERBERG – MARKETING DIRECTOR

Born: 1975

Fredrik was employed by Episurf Medical AB in February 2016 and has 25 years of experience from medical technology companies such as Baxter, Cardinal Health, ArthroCare and Smith & Nephew.

Since 2008 the focus has been on orthopedics where he has held senior positions within sales management and international marketing.

Other appointments:-

No of B shares: 26,500

No of employee stock options: –

No of performance options: 558,700

No of warrants: –

 

 

 

 

PATRICK JAMNIK – PRESIDENT, EPISURF MEDICAL INC 

Born: 1983

Patrick has almost 20 years of global market development experience, building businesses across multiple orthopaedic disciplines in both Europe and the US. He has previously held commercial leadership positions at Stryker, Zimmer-Biomet, Stanmore Implants, and InspireMD. While at UK-based Stanmore Implants, he played a central role in establishing, commercialising, and growing its US business, leading to its eventual acquisition by Stryker. Patrick has a Bachelor’s Degree and MBA from the University of Wisconsin-Madison.

Other appointments: Board member Askel Healthcare Oy

No of B shares: 268,050

No of employee stock options: –

No of performance options: 678,814

No of warrants: –

 

YLVA BONDE – Head of QA/RA

Born: 1979

Ylva has a doctorate in medical science from Karolinska Institutet, a master’s degree in nutrition from Stockholm University, and six years of experience in medical research. For four years, Ylva has worked at a company as a quality manager and consultant in quality assurance and the regulatory area related to medical technology. She has been employed by Episurf Medical since 2024.

Other appointments: –

No of B shares: –

No of employee stock options: –

No of performance options: –

No of warrants: –

Updated 2024-05-31